Sigma-Aldrich Acquires Cerilliant

The deal strengthens Sigma-Aldrich's analytical chemistry product portfolio and brings to it more than 2,800 products that support the clinical diagnostics, environmental, nutraceutical, pharmaceutical, forensic, and clinical toxicology markets.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories